Quest Diagnostics
DGX
#1095
Rank
โ‚น1.834 T
Marketcap
โ‚น16,407
Share price
-0.91%
Change (1 day)
23.98%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2025 (TTM): โ‚น111.29 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น10.85 Billion. In 2024 the company made an earning of โ‚น105.62 Billion, an increase over its 2023 earnings that were of โ‚น101.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น111.29 B5.36%
2024 โ‚น105.62 B3.98%
2023 โ‚น101.58 B-8.5%
2022 โ‚น111.02 B-52.48%
2021 โ‚น233.63 B37.95%
2020 โ‚น169.36 B75.09%
2019 โ‚น96.72 B16.2%
2018 โ‚น83.24 B-10.1%
2017 โ‚น92.59 B-5.16%
2016 โ‚น97.62 B-1.54%
2015 โ‚น99.15 B31%
2014 โ‚น75.69 B-37.52%
2013 โ‚น121.15 B26.93%
2012 โ‚น95.45 B24.01%
2011 โ‚น76.97 B-27.7%
2010 โ‚น106.46 B-3.55%
2009 โ‚น110.38 B19.59%
2008 โ‚น92.30 B12.54%
2007 โ‚น82.02 B-11.7%
2006 โ‚น92.88 B13.49%
2005 โ‚น81.84 B9.02%
2004 โ‚น75.07 B13.19%
2003 โ‚น66.32 B36.03%
2002 โ‚น48.75 B63.07%
2001 โ‚น29.89 B65.49%
2000 โ‚น18.06 B1297.84%
1999 โ‚น1.29 B-73.37%
1998 โ‚น4.85 B-384.21%
1997 -โ‚น1.71 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น119.84 B 3.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.18 Billion-100.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.82 Billion-108.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.71 Billion-100.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.74 B-96.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น48.65 B-57.95%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands